SOMX Insider Trading Activity and SEC Form 4 Filings
SOMX insider trading summary
No open-market insider purchases or sales of Somaxon Pharmaceuticals, Inc. (SOMX) have been reported on SEC Form 4 in the past 12 months.
Latest SOMX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 2, 2013 | Tran Nguyen | SVP and CFO | Sell | $1K (412 @ $3.08) |
| Sep 5, 2012 | Kurt Von Emster | Director | Sell | $396 (1,367 @ $0.29) |
| Jul 9, 2012 | MPM BIOVENTURES III GMBH & CO. Beteiligungs KG | 10% Owner | Sell | $499K (1,624,574 @ $0.31) |
| Jul 9, 2012 | Ansbert Gadicke | 10% Owner | Sell | $499K (1,624,574 @ $0.31) |
| Jul 9, 2012 | Mpm Bioventures III LLC | 10% Owner | Sell | $499K (1,624,574 @ $0.31) |
| Jul 9, 2012 | Kurt Wheeler | 10% Owner | Sell | $499K (1,624,574 @ $0.31) |
| Jul 9, 2012 | Dennis Henner | 10% Owner | Sell | $499K (1,624,574 @ $0.31) |
| Jul 9, 2012 | Michael Steinmetz | 10% Owner | Sell | $499K (1,624,574 @ $0.31) |
| Jul 9, 2012 | Mpm Bioventures Iii-Qp L.P. | 10% Owner | Sell | $499K (1,624,574 @ $0.31) |
| Jul 9, 2012 | MPM Asset Management Investors 2005 BVIII LLC | 10% Owner | Sell | $499K (1,624,574 @ $0.31) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.